Ilya Pharma today announced that it has been invited to present its ILP100 accelerated wound healing therapy at the US Military Health System Research Symposium (MHSRS) 2021 to be held 23-26 August at the Gaylord Convention Center in Florida.
Ilya Pharma, a clinical stage gene therapy company today announced that Sylvia McBrinn has joined the Board, while Oskar Lund has been appointed Chief Financial Officer.